Sign up to save your podcasts
Or
Share 54. The Challenges Behind Creating an FDA Approved Drug for Interstitial Cystitis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
54. The Challenges Behind Creating an FDA Approved Drug for Interstitial Cystitis
In this episode of The Women's Pelvic Health Podcast I am joined by Abigail Jenkins, an ICA (Interstitial Cystitis Association) Board member and pharmaceutical executive who has been involved in the development of a drug for IC. Abigal has worked in the pharmaceutical industry for over 20 years. She shares valuable insight into the pharmaceutical industry and the challenges that go into creating a drug for Interstitial Cystitis.
Thank you for listening and I wish all of you health, healing and happiness.
View all episodes
By The V HiveIn this episode of The Women's Pelvic Health Podcast I am joined by Abigail Jenkins, an ICA (Interstitial Cystitis Association) Board member and pharmaceutical executive who has been involved in the development of a drug for IC. Abigal has worked in the pharmaceutical industry for over 20 years. She shares valuable insight into the pharmaceutical industry and the challenges that go into creating a drug for Interstitial Cystitis.
Thank you for listening and I wish all of you health, healing and happiness.